Literature DB >> 9418137

CD79 alpha/CD79 beta heterodimers are expressed on pro-B cell surfaces without associated mu heavy chain.

M Koyama1, K Ishihara, H Karasuyama, J L Cordell, A Iwamoto, T Nakamura.   

Abstract

During B cell development, the surface expression of CD79 alpha/CD79 beta heterodimers had been thought to begin in the pre-B cell stage where the heterodimers constitute pre-B cell receptors together with mu heavy and surrogate light chains. Thereafter, in mature B cells, CD79 alpha/CD79 beta associates with surface Ig to form B cell antigen receptors. In this study, we revealed by using newly established mAb that CD79 beta was expressed on the surface of pro-B cells which had not undergone the productive Ig gene rearrangement. Biochemical analysis showed that CD79 beta on pro-B cells existed either as monomers or as disulfide-linked heterodimers with CD79 alpha, non-covalently associated with four unidentified membrane molecules. Our finding that CD79 beta is expressed on earlier B-lineage cells than previously expected coincides with the recent study in which CD79 beta-deficient mice exhibit a blockade of B cell differentiation at the pro-B cell stage. Thus, it is speculated that the CD79 beta-containing complexes on pro-B cell surfaces may function to induce early B cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418137     DOI: 10.1093/intimm/9.11.1767

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  Mutations in Igalpha (CD79a) result in a complete block in B-cell development.

Authors:  Y Minegishi; E Coustan-Smith; L Rapalus; F Ersoy; D Campana; M E Conley
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization.

Authors:  B J Vilen; T Nakamura; J C Cambier
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

3.  The transmembrane tyrosine of micro-heavy chain is required for BCR destabilization and entry of antigen into clathrin-coated vesicles.

Authors:  Jin Hyang Kim; Jennifer A Rutan; Barbara J Vilen
Journal:  Int Immunol       Date:  2007-11-01       Impact factor: 4.823

4.  In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in mice.

Authors:  Daniel L J Thorek; Patricia Y Tsao; Vaishali Arora; Lanlan Zhou; Robert A Eisenberg; Andrew Tsourkas
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

5.  Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.

Authors:  Christian Hurtz; Gerald B Wertheim; Joseph P Loftus; Daniel Blumenthal; Anne Lehman; Yong Li; Asen Bagashev; Bryan Manning; Katherine D Cummins; Janis K Burkhardt; Alexander E Perl; Martin Carroll; Sarah K Tasian
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

6.  Cloning of a hamster anti-mouse CD79B antibody sequences and identification of a new hamster immunoglobulin lambda constant IGLC gene region.

Authors:  Ryan Haggart; Jason Perera; Haochu Huang
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

7.  B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice.

Authors:  Yongmei Li; Fangqi Chen; Mary Putt; Yumee K Koo; Michael Madaio; John C Cambier; Philip L Cohen; Robert A Eisenberg
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

8.  Early postnatal B cell ontogeny and antibody repertoire maturation in the opossum, Monodelphis domestica.

Authors:  Xinxin Wang; Alana R Sharp; Robert D Miller
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

9.  Immunoglobulin beta signaling regulates locus accessibility for ordered immunoglobulin gene rearrangements.

Authors:  K Maki; K Nagata; F Kitamura; T Takemori; H Karasuyama
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

10.  B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta.

Authors:  A Reichlin; Y Hu; E Meffre; H Nagaoka; S Gong; M Kraus; K Rajewsky; M C Nussenzweig
Journal:  J Exp Med       Date:  2001-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.